Good News: Parkinson's Disease Biomarker Found
The Michael J. Fox Foundation announced the most significant breakthrough to date in the search for a Parkinson’s biomarker: a highly accurate biological test for Parkinson’s disease. The test is capable of objectively and reliably detecting the disease at the molecular level, even before the onset of symptoms.
The discovery of this biomarker could lead to earlier diagnosis and treatment of Parkinson's disease, which could help to improve the quality of life for people with the disease.
The breakthrough, published in the scientific journal The Lancet Neurology, opens a new chapter for research, with the promise of a future where every person living with Parkinson’s can expect improved care and treatments — and newly diagnosed individuals may never advance to full-blown symptoms.
Parkinson's disease affects people differently, with some people progressing more rapidly than others. Research into the structural changes in the proteins involved in Parkinson's may help us to better understand why there is such variation in the progression of the condition.